456 related articles for article (PubMed ID: 17652280)
1. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
2. Incidence of and treatment for ductal carcinoma in situ of the breast.
Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
[TBL] [Abstract][Full Text] [Related]
3. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
4. Bilateral breast cancer: early detection with mammography.
Roubidoux MA; Helvie MA; Lai NE; Paramagul C
Radiology; 1995 Aug; 196(2):427-31. PubMed ID: 7617856
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.
Li CI; Weiss NS; Stanford JL; Daling JR
Cancer; 2000 Jun; 88(11):2570-7. PubMed ID: 10861435
[TBL] [Abstract][Full Text] [Related]
6. Mammography screening and the increase in breast cancer incidence in Hawaii.
Maskarinec G; Wilkens L; Meng L
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):201-8. PubMed ID: 9138664
[TBL] [Abstract][Full Text] [Related]
7. Trends of in situ carcinoma of the breast in Vaud, Switzerland.
Levi F; Te VC; Randimbison L; La Vecchia C
Eur J Cancer; 1997 May; 33(6):903-6. PubMed ID: 9291813
[TBL] [Abstract][Full Text] [Related]
8. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
[TBL] [Abstract][Full Text] [Related]
9. [Hormone replacement therapy in menopause and risk of breast cancer].
Clavel-Chapelon F; Hill C
Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
[TBL] [Abstract][Full Text] [Related]
10. To screen or not to screen: the issue of breast cancer screening in older women.
Caplan LS
Public Health Rev; 2001; 29(2-4):231-40. PubMed ID: 12418709
[TBL] [Abstract][Full Text] [Related]
11. Recent trends in U.S. breast cancer incidence, survival, and mortality rates.
Chu KC; Tarone RE; Kessler LG; Ries LA; Hankey BF; Miller BA; Edwards BK
J Natl Cancer Inst; 1996 Nov; 88(21):1571-9. PubMed ID: 8901855
[TBL] [Abstract][Full Text] [Related]
12. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.
Ernster VL; Barclay J
J Natl Cancer Inst Monogr; 1997; (22):151-6. PubMed ID: 9709292
[TBL] [Abstract][Full Text] [Related]
13. The greater impact of menopause on ER- than ER+ breast cancer incidence: a possible explanation (United States).
Tarone RE; Chu KC
Cancer Causes Control; 2002 Feb; 13(1):7-14. PubMed ID: 11899120
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy in relation to breast cancer.
Chen CL; Weiss NS; Newcomb P; Barlow W; White E
JAMA; 2002 Feb; 287(6):734-41. PubMed ID: 11851540
[TBL] [Abstract][Full Text] [Related]
15. Increase in breast cancer incidence in middle-aged women during the 1990s.
Prehn A; Clarke C; Topol B; Glaser S; West D
Ann Epidemiol; 2002 Oct; 12(7):476-81. PubMed ID: 12377425
[TBL] [Abstract][Full Text] [Related]
16. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.
Magnusson C; Baron JA; Correia N; Bergström R; Adami HO; Persson I
Int J Cancer; 1999 May; 81(3):339-44. PubMed ID: 10209946
[TBL] [Abstract][Full Text] [Related]
17. Rising incidence of breast cancer: relationship to stage and receptor status.
Glass AG; Hoover RN
J Natl Cancer Inst; 1990 Apr; 82(8):693-6. PubMed ID: 2319611
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.
Tabar L; Fagerberg G; Chen HH; Duffy SW; Smart CR; Gad A; Smith RA
Cancer; 1995 May; 75(10):2507-17. PubMed ID: 7736395
[TBL] [Abstract][Full Text] [Related]
19. Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer.
Bonnier P; Bessenay F; Sasco AJ; Beedassy B; Lejeune C; Romain S; Charpin C; Piana L; Martin PM
Int J Cancer; 1998 Jun; 79(3):278-82. PubMed ID: 9645351
[TBL] [Abstract][Full Text] [Related]
20. Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography.
Lee JM; Abraham L; Lam DL; Buist DSM; Kerlikowske K; Miglioretti DL; Houssami N; Lehman CD; Henderson LM; Hubbard RA
J Clin Oncol; 2018 Jul; 36(20):2070-2077. PubMed ID: 29718790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
